TABLE 3.

Three-year Conditional Disease-free Survival Rates of Patients in Relationship to Clinicopathologic Features

	Conditional 3-yr Disease-free Survival, %
Variables	At Surgery	1 yr After Surgery	2 yrs After Surgery	3 yrs After Surgery	5 yrs After Surgery
All patients	34.3%	42.6%	51.2%	53.4%	70.2%
Age
≤65 yrs	37.2%	44.6%	50.8%	49.0%	65.5%
>65 yrs	18.4%	31.5%	53.6%	100.0%	100.0%
|d|	0.39	0.27	0.06	1.04	0.75
Sex
Female	33.6%	43.3%	55.9%	56.8%	79.5%
Male	35.4%	40.8%	42.9%	47.6%	53.6%
|d|	0.04	0.05	0.26	0.18	0.61
Mitotic Index
≤10/50 HPR	33.2%	50.0%	59.5%	76.2%	68.5%
>10/50 HPR	20.9%	34.1%	23.4%	37.5%	100.0%
|d|	0.27	0.32	0.73	0.84	0.74
Size
≤10cm	43.8%	50.5%	49.8%	50.8%	77.1%
>10 cm	28.9%	38.7%	54.9%	55.3%	64.2%
|d|	0.31	0.24	0.10	0.09	0.28
Capsular invasion
No	50.6%	47.9%	47.3%	55.2%	87.5%
Yes	27.7%	45.0%	54.8%	60.9%	87.5%
|d|	0.47	0.06	0.15	0.12	0
T stage
I & II	45.0%	59.8%	62.8%	68.4%	76.2%
III & IV	21.6%	21.9%	30.6%	33.5%	79.9%
|d|	0.49	0.76	0.65	0.71	0.09
Margin
R0	37.2%	45.2%	54.7%	63.1%	79.6%
R1/R2	20.0%	31.2%	37.5%	33.4%	—
|d|	0.36	0.28	0.35	0.60
Functional tumors
No	43.5%	47.6%	56.4%	56.0%	77.8%
Yes	19.5%	33.6%	46.0%	62.5%	83.4%
|d|	0.49	0.28	0.21	0.13	0.14